Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Mesalamine Extended-Release Capsules/Pentasa

Mesalazine sustained-release tablets are indicated for 1. Acute treatment of ulcerative colitis (inflammation with ulcers) and maintenance treatment to prevent relapse. 2. Symptom improvement of active Crohn’s disease.

Share: